Park S S
Albert Einstein College of Medicine, Bronx, New York.
Lung. 1993;171(6):311-33. doi: 10.1007/BF00165698.
Although the Starling resistor behavior of the upper airway during sleep has been well established in health and disease, its physiological implications have not been fully appreciated. The purposes of the present communication are to reassess the current state of knowledge within the framework of the Starling resistor concept and to examine the implications of the concept on homeostatic feedback respiratory control and the pathogenesis of the sleep apnea syndrome. The main inferences drawn from the assessment include: (1) Owing to the Starling resistor properties of the upper airway and the well-organized neurochemical control mechanism, the upper airway performs important homeostatic flow regulatory function; it appropriately dampens the potentially unstable breathing during sleep and prevents the PaCO2 from falling below the apneic threshold; (2) Under certain conditions, the upper airway flow regulatory function fails to achieve appropriate dampening, leading to development of a variety of sleep-related breathing disorders that include underdamping due to overly sensitive central chemoresponsiveness and/or excessive lung to chemoreceptor transport lag--central sleep apnea; overdamping due to upper airway obstructive dysfunction--obstructive sleep apnea and/or hypopnea; and, finally, conditions with mixed features of central underdamping with coexisting collapsible upper airway; and (3) Successful treatment of these conditions requires restoration of appropriate damping. The overdamping imposed by the faulty upper airway is effectively reduced by surgical and medical approaches, and by application of nasal continuous positive airway pressure (CPAP). Reduction of PaCO2 by use of acetalzolamide and/or aminophylline reduces the plant gain, thus effectively offsetting the underdamping of central origin. Owing to the dual effect of nasal CPAP on the upper airway and respiratory pump, use of nasal CPAP can also effectively reduce the plant gain, accounting for the therapeutic effect of nasal CPAP on the central sleep apnea.
尽管上气道在睡眠期间的“斯塔林电阻器”行为在健康和疾病状态下已得到充分证实,但其生理意义尚未得到充分认识。本通讯的目的是在“斯塔林电阻器”概念的框架内重新评估当前的知识状态,并探讨该概念对稳态反馈呼吸控制和睡眠呼吸暂停综合征发病机制的影响。评估得出的主要推论包括:(1)由于上气道的“斯塔林电阻器”特性和组织良好的神经化学控制机制,上气道发挥着重要的稳态流量调节功能;它能适当抑制睡眠期间潜在不稳定的呼吸,并防止动脉血二氧化碳分压(PaCO2)降至呼吸暂停阈值以下;(2)在某些情况下,上气道流量调节功能无法实现适当的抑制,导致多种与睡眠相关的呼吸障碍的发生,包括由于中枢化学感受器反应过度敏感和/或肺到化学感受器的传输延迟过长导致的抑制不足——中枢性睡眠呼吸暂停;由于上气道阻塞性功能障碍导致的过度抑制——阻塞性睡眠呼吸暂停和/或呼吸不足;最后,还有中枢抑制不足与并存的可塌陷上气道混合特征的情况;(3)成功治疗这些疾病需要恢复适当的抑制。通过手术和药物方法,以及应用鼻持续气道正压通气(CPAP),可有效减轻上气道功能异常所造成的过度抑制。使用乙酰唑胺和/或氨茶碱降低PaCO2可降低呼吸系统增益,从而有效抵消中枢性起源的抑制不足。由于鼻CPAP对上气道和呼吸泵的双重作用,使用鼻CPAP也可有效降低呼吸系统增益,这解释了鼻CPAP对中枢性睡眠呼吸暂停的治疗作用。